Detalles de la búsqueda
1.
Clinical and molecular characteristics of non-small-cell lung cancer (NSCLC) harboring EGFR mutation: results of the nationwide French Cooperative Thoracic Intergroup (IFCT) program.
Ann Oncol
; 28(11): 2715-2724, 2017 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28945865
2.
Randomized phase II-III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: results from the IFCT-0802 trial.
Ann Oncol
; 26(5): 908-914, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25688059
3.
Final results of the IFCT-0803 study, a phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non-squamous, non-small-cell lung cancer.
Cancer Radiother
; 26(5): 670-677, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35260342
4.
IFCT-1502 CLINIVO: real-world evidence of long-term survival with nivolumab in a nationwide cohort of patients with advanced non-small-cell lung cancer.
ESMO Open
; 7(1): 100353, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34953398
5.
PTEN, ATM, IDH1 mutations and MAPK pathway activation as modulators of PFS and OS in patients treated by first line EGFR TKI, an ancillary study of the French Cooperative Thoracic Intergroup (IFCT) Biomarkers France project.
Lung Cancer
; 151: 69-75, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33248711
6.
Diffusion coefficients of respiratory gases in a perfluorocarbon liquid.
Science
; 217(4555): 153-5, 1982 Jul 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-6806902
Resultados
1 -
6
de 6
1
Próxima >
>>